118 related articles for article (PubMed ID: 10885487)
1. Plasma concentrations of blood coagulation factor VII measured by immunochemical and amidolytic methods.
Bladbjerg EM; Gram J; Jespersen J
Scand J Clin Lab Invest; 2000 May; 60(3):161-8. PubMed ID: 10885487
[TBL] [Abstract][Full Text] [Related]
2. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.
Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
Thromb Res; 1997 Jun; 86(6):493-504. PubMed ID: 9219329
[TBL] [Abstract][Full Text] [Related]
3. The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum.
Bladbjerg EM; Overgaard K; Gram J; Jespersen J
Scand J Clin Lab Invest; 1995 May; 55(3):267-71. PubMed ID: 7638562
[TBL] [Abstract][Full Text] [Related]
4. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1170-6. PubMed ID: 8792771
[TBL] [Abstract][Full Text] [Related]
5. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
6. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
Kario K; Miyata T; Sakata T; Matsuo T; Kato H
Arterioscler Thromb; 1994 Feb; 14(2):265-74. PubMed ID: 8305419
[TBL] [Abstract][Full Text] [Related]
7. Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis.
Bladbjerg EM; Münster AM; Marckmann P; Keller N; Jespersen J
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2494-9. PubMed ID: 11073858
[TBL] [Abstract][Full Text] [Related]
8. Canine specific ELISA for coagulation factor VII.
Knudsen T; Kjelgaard-Hansen M; Tranholm M; Wiinberg B; Clausen JT; Hansen JJ; Nichols TC; Kjalke M; Jensen AL; Kristensen AT
Vet J; 2011 Dec; 190(3):352-8. PubMed ID: 21216638
[TBL] [Abstract][Full Text] [Related]
9. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
[TBL] [Abstract][Full Text] [Related]
10. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?
Giansily-Blaizot M; Verdier R; Biron-Adréani C; Schved JF; Bertrand MA; Borg JY; Le Cam-Duchez V; Briquel ME; Chambost H; Pouymayou K; Dutrillaux F; Favier R; Martin-Toutain I; Verdy E; Gay V; Goudemand J; Navarro R; Durin A; d'Oiron R; Lambert T; Pernod G; Barrot C; Peynet J; Bastenaire B; Sie P; Stieltjes N; Torchet MF; de Moerloose P;
Haematologica; 2004 Jun; 89(6):704-9. PubMed ID: 15194538
[TBL] [Abstract][Full Text] [Related]
11. Factor VII and activated-factor-VII content of prothrombin complex concentrates. The PCC Study Group.
Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
Vox Sang; 1997; 73(3):155-61. PubMed ID: 9358617
[TBL] [Abstract][Full Text] [Related]
12. A high-fat meal does not activate blood coagulation factor VII in minipigs.
Olsen AK; Larsen LF; Bladbjerg EM; Hansen AK; Jespersen J; Marckmann P
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):117-22. PubMed ID: 11302473
[TBL] [Abstract][Full Text] [Related]
13. A patient homozygous for a Gly354Cys mutation in factor VII that results in severely impaired secretion of the molecule, but not complete deficiency.
Takamiya O; Hino K
Br J Haematol; 2004 Feb; 124(3):336-42. PubMed ID: 14717781
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas.
Giansily-Blaizot M; Al Dieri R; Schved JF
Pathophysiol Haemost Thromb; 2003; 33(1):36-42. PubMed ID: 12853711
[TBL] [Abstract][Full Text] [Related]
15. Standardization of factor VII/activated factor VII measurement in plasma of patients treated with recombinant factor activated VII.
Goudemand J; Caron C; Dreyfus M; Sié P;
Blood Coagul Fibrinolysis; 2003 Jul; 14(5):505-11. PubMed ID: 12851539
[TBL] [Abstract][Full Text] [Related]
16. Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency.
Tran HT; Tjønnfjord GE; Holme PA
Haemophilia; 2014 Jan; 20(1):141-6. PubMed ID: 23992369
[TBL] [Abstract][Full Text] [Related]
17. A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
Sun Y; Jia L; Yang Z; Chen W
Medicine (Baltimore); 2018 Nov; 97(44):e12776. PubMed ID: 30383632
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
[TBL] [Abstract][Full Text] [Related]
19. Isotypic analysis of antibodies against activated Factor VII in patients with Factor VII deficiency using the x-MAP technology.
Pfeiffer C; Mathieu-Dupas E; Logghe P; Lissalde-Lavigne G; Balicchi J; Caliskan U; Valentin T; Laune D; Molina F; Schved JF; Giansily-Blaizot M
Thromb Res; 2016 May; 141():22-7. PubMed ID: 26962982
[TBL] [Abstract][Full Text] [Related]
20. Factor VII and extrinsic pathway inhibitor in acute coronary disease.
Sandset PM; Sirnes PA; Abildgaard U
Br J Haematol; 1989 Jul; 72(3):391-6. PubMed ID: 2788454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
